536 related articles for article (PubMed ID: 28653186)
1. Ebola Virus Disease in Humans: Pathophysiology and Immunity.
Muñoz-Fontela C; McElroy AK
Curr Top Microbiol Immunol; 2017; 411():141-169. PubMed ID: 28653186
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease.
Kucharski AJ; Eggo RM; Watson CH; Camacho A; Funk S; Edmunds WJ
Emerg Infect Dis; 2016 Jan; 22(1):105-8. PubMed ID: 26691346
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
4. The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.
O'Donnell K; Marzi A
Expert Rev Vaccines; 2020 Mar; 19(3):267-277. PubMed ID: 32129120
[No Abstract] [Full Text] [Related]
5. Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.
Yoshida R; Muramatsu S; Akita H; Saito Y; Kuwahara M; Kato D; Changula K; Miyamoto H; Kajihara M; Manzoor R; Furuyama W; Marzi A; Feldmann H; Mweene A; Masumu J; Kapeteshi J; Muyembe-Tamfum JJ; Takada A
J Infect Dis; 2016 Oct; 214(suppl 3):S185-S191. PubMed ID: 27462094
[TBL] [Abstract][Full Text] [Related]
6. Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks.
Matson MJ; Chertow DS; Munster VJ
Emerg Microbes Infect; 2020; 9(1):291-301. PubMed ID: 32013784
[TBL] [Abstract][Full Text] [Related]
7. Immune barriers of Ebola virus infection.
McElroy AK; Mühlberger E; Muñoz-Fontela C
Curr Opin Virol; 2018 Feb; 28():152-160. PubMed ID: 29452995
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus disease in the Democratic Republic of Congo.
Maganga GD; Kapetshi J; Berthet N; Kebela Ilunga B; Kabange F; Mbala Kingebeni P; Mondonge V; Muyembe JJ; Bertherat E; Briand S; Cabore J; Epelboin A; Formenty P; Kobinger G; González-Angulo L; Labouba I; Manuguerra JC; Okwo-Bele JM; Dye C; Leroy EM
N Engl J Med; 2014 Nov; 371(22):2083-91. PubMed ID: 25317743
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological situation of Ebola virus disease in West Africa].
Arima Y; Shimada T
Uirusu; 2015; 65(1):47-54. PubMed ID: 26923957
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Review on Ebola (EBOV) Virus: Future Prospects.
Khan S; Muhammad ; Rauf A; Khan A; Rizwan M; Patel S; Khan H; Mahasneh AM; Mubarak MS
Infect Disord Drug Targets; 2018; 18(2):96-104. PubMed ID: 28820067
[TBL] [Abstract][Full Text] [Related]
11. Ebola virus disease and the veterinary perspective.
Gumusova S; Sunbul M; Leblebicioglu H
Ann Clin Microbiol Antimicrob; 2015 May; 14():30. PubMed ID: 26018030
[TBL] [Abstract][Full Text] [Related]
12. Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak.
Olabode AS; Jiang X; Robertson DL; Lovell SC
Virology; 2015 Aug; 482():202-7. PubMed ID: 25880111
[TBL] [Abstract][Full Text] [Related]
13. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection.
Dahlke C; Lunemann S; Kasonta R; Kreuels B; Schmiedel S; Ly ML; Fehling SK; Strecker T; Becker S; Altfeld M; Sow A; Lohse AW; Muñoz-Fontela C; Addo MM
J Infect Dis; 2017 Jan; 215(2):287-292. PubMed ID: 27799354
[TBL] [Abstract][Full Text] [Related]
15. Ebola viral disease: What should be done to combat the epidemic in 2014?
Baştuğ A; Bodur H
Turk J Med Sci; 2015; 45(1):1-5. PubMed ID: 25790522
[TBL] [Abstract][Full Text] [Related]
16. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
17. Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa.
Subissi L; Keita M; Mesfin S; Rezza G; Diallo B; Van Gucht S; Musa EO; Yoti Z; Keita S; Djingarey MH; Diallo AB; Fall IS
J Infect Dis; 2018 Nov; 218(suppl_5):S287-S291. PubMed ID: 29920602
[TBL] [Abstract][Full Text] [Related]
18. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
Houlihan CF; McGowan CR; Dicks S; Baguelin M; Moore DAJ; Mabey D; Roberts CH; Kumar A; Samuel D; Tedder R; Glynn JR
PLoS Med; 2017 May; 14(5):e1002300. PubMed ID: 28510604
[TBL] [Abstract][Full Text] [Related]
19. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
Cross RW; Boisen ML; Millett MM; Nelson DS; Oottamasathien D; Hartnett JN; Jones AB; Goba A; Momoh M; Fullah M; Bornholdt ZA; Fusco ML; Abelson DM; Oda S; Brown BL; Pham H; Rowland MM; Agans KN; Geisbert JB; Heinrich ML; Kulakosky PC; Shaffer JG; Schieffelin JS; Kargbo B; Gbetuwa M; Gevao SM; Wilson RB; Saphire EO; Pitts KR; Khan SH; Grant DS; Geisbert TW; Branco LM; Garry RF
J Infect Dis; 2016 Oct; 214(suppl 3):S210-S217. PubMed ID: 27587634
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CD8
Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
